Estimation of an Optimal Chemotherapy Utilisation Rate for Primary Malignant Brain Tumours: an Evidence-based Benchmark for Cancer Care

The optimal chemotherapy utilisation rate can serve as an evidence-based benchmark in the planning and evaluation of chemotherapy services for brain cancer. There are no recent published patterns of care studies that report on chemotherapy utilisation rates for primary malignant brain tumours; future research should focus on filling this gap.